XML 192 R49.htm IDEA: XBRL DOCUMENT v3.25.2
Stock-Based Compensation (Tables)
3 Months Ended 12 Months Ended
Mar. 31, 2025
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]    
Summary of Stock-based Compensation Expense
The Company recorded stock-based compensation expense for stock options and RSUs as follows:
 
    
Three Months Ended

March 31,
 
(Amounts in thousands)
  
2025
    
2024
 
Research and development
   $ 5,975      $ 180  
Selling, general and administrative
     5,065        157  
  
 
 
    
 
 
 
Total
   $ 11,040      $ 337  
  
 
 
    
 
 
 
 
 
The Company recorded stock-based compensation expense for stock options and the
2024
cancellation of
135,400
RSUs during the years ended December 
31
,
2024
and
2023
, as follows (in thousands):
 
 
  
2024
 
  
2023
 
Research and development
   $ 1,106      $ 372  
Selling, general and administrative
     2,741        2,111  
Total
   $ 3,847      $ 2,483  
Summary of Stock Option Activity
A summary of stock option activity under the 2011 Amended Plan is as follows:
 
    
Number of

Options
    
Weighted

average

exercise price
    
Weighted

average

remaining

contractual

life

(in years)
    
Aggregate

intrinsic

value

(in thousands)
 
Outstanding as of December 31, 2024
     28,360,635      $ 1.27        9.2      $ 22,741  
Forfeited
     (318,400      1.18        
  
 
 
    
 
 
       
Outstanding as of March 31, 2025
     28,042,235      $ 1.27        8.9        30,225  
  
 
 
    
 
 
       
Vested and expected to vest as of March 31, 2025
     28,042,235      $ 1.27        8.9        30,225  
  
 
 
    
 
 
       
Exercisable as of March 31, 2025
     8,472,388      $ 1.87        8.1        10,342  
  
 
 
    
 
 
       
A summary of stock option activity as of December 31, 2024 is as follows:
 

 
  
Number of
options
outstanding
 
 
Weighted
average
exercise price
 
  
Weighted
average
remaining
contractual life
 
  
Aggregate
intrinsic value
(in thousands)
 
Outstanding options at December 31, 2022
     1,325,844      $ 9.10        5.6      $ 925  
Granted
     15,141,280        0.44        
Exercised
     (1,000      0.80        
Expired
     (8,601      0.80        
Forfeited
     (19,543      15.53        
  
 
 
    
 
 
       
Outstanding options at December 31, 2023
     16,437,980      $ 1.12        9.3      $ 13,907  
Granted
     21,329,457        0.92        
Exercised
     (65,646      1.49        
Expired
     (5,500      0.74        
Forfeited
     (1,333,107      1.54        
  
 
 
    
 
 
       
Outstanding options at December 31, 2024
     36,363,184      $ 0.99        9.2      $ 22,845  
  
 
 
    
 
 
       
Vested/expected to vest at December 31, 2024
     35,560,434      $ 0.99        9.1      $ 22,492  
Exercisable options at December 31, 2024
     9,614,865      $ 1.58        8.3      $ 7,066  
Summary of RSU Activity Issued
A summary of the Company’s RSU activity issued under the 2011 Amended Plan is as follows:
 
    
RSUs Awarded
    
Weighted

average grant

date fair value
 
Nonvested as of December 31, 2024
     3,630,447      $ 1.53  
Vested
     (2,464,171      1.76  
Forfeited
     (15,552      0.73  
  
 
 
    
 
 
 
Nonvested as of March 31, 2025
     1,150,724      $ 1.04  
  
 
 
    
 
 
 
A summary of the Company’s RSU activity issued under the 2011 Amended Plan, inclusive of the
6,000,000 RSUs issued to an investor (see Notes 7 and 13), for the years ended December 31, 2024 and 2023 is as follows:
 
 
  
Awards
 
  
Weighted-
average grant
date fair value
(per share)
 
Nonvested as of January 1, 2023
     137,909      $ 15.28  
Issued
     10,929,820      $ 0.60  
Exercised
     (6,000,000    $ 0.44  
Forfeited
     (150,900    $ 1.98  
  
 
 
    
 
 
 
Nonvested as of December 31, 2023
     4,916,829      $ 1.18  
Forfeited
     (254,555    $ 0.88  
Expired
     (7,000    $ 0.82  
  
 
 
    
 
 
 
Nonvested as of December 31, 2024
     4,655,274      $ 1.19